To Predict the Requirement of Pharmacotherapy by OGTT Glucose Levels in Women with GDM Classified by the IADPSG Criteria

The aim of this study was to assess the association between OGTT glucose levels and requirement of pharmacotherapy in GDM patients classified by the IADPSG criteria. This study included 203 GDM patients (108 managed with lifestyle modification and 95 requiring pharmacotherapy). Clinical risk factors...

Full description

Saved in:
Bibliographic Details
Main Authors: Gülen Yerlikaya, Veronica Falcone, Tina Stopp, Martina Mittlböck, Andrea Tura, Peter Husslein, Wolfgang Eppel, Christian S. Göbl
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2018/3243754
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558983694516224
author Gülen Yerlikaya
Veronica Falcone
Tina Stopp
Martina Mittlböck
Andrea Tura
Peter Husslein
Wolfgang Eppel
Christian S. Göbl
author_facet Gülen Yerlikaya
Veronica Falcone
Tina Stopp
Martina Mittlböck
Andrea Tura
Peter Husslein
Wolfgang Eppel
Christian S. Göbl
author_sort Gülen Yerlikaya
collection DOAJ
description The aim of this study was to assess the association between OGTT glucose levels and requirement of pharmacotherapy in GDM patients classified by the IADPSG criteria. This study included 203 GDM patients (108 managed with lifestyle modification and 95 requiring pharmacotherapy). Clinical risk factors and OGTT glucose concentrations at 0 (G0), 60 (G60), and 120 min (G120) were collected. OGTT glucose levels were significantly associated with the later requirement of pharmacotherapy (ROC-AUC: 71.1, 95% CI: 63.8–78.3). Also, the combination of clinical risk factors (age, BMI, parity, and pharmacotherapy in previous gestation) showed an acceptable predictive accuracy (ROC-AUC: 72.1, 95% CI: 65.0–79.2), which was further improved when glycemic parameters were added (ROC-AUC: 77.5, 95% CI: 71.5–83.9). Random forest analysis revealed the highest variable importance for G0, G60, and age. OGTT glucose measures in addition to clinical risk factors showed promising properties for risk stratification in GDM patients classified by the recently established IADPSG criteria.
format Article
id doaj-art-193d7a450f5449f9a2110c32736fa96a
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-193d7a450f5449f9a2110c32736fa96a2025-02-03T01:31:04ZengWileyJournal of Diabetes Research2314-67452314-67532018-01-01201810.1155/2018/32437543243754To Predict the Requirement of Pharmacotherapy by OGTT Glucose Levels in Women with GDM Classified by the IADPSG CriteriaGülen Yerlikaya0Veronica Falcone1Tina Stopp2Martina Mittlböck3Andrea Tura4Peter Husslein5Wolfgang Eppel6Christian S. Göbl7Department of Obstetrics and Gynecology, Division of Obstetrics and Feto-Naternal Medicine, Medical University of Vienna, Vienna, AustriaDepartment of Obstetrics and Gynecology, Division of Obstetrics and Feto-Naternal Medicine, Medical University of Vienna, Vienna, AustriaDepartment of Obstetrics and Gynecology, Division of Obstetrics and Feto-Naternal Medicine, Medical University of Vienna, Vienna, AustriaCenter of Medical Statistics, Informatics, and Intelligent Systems, Section for Clinical Biometrics, Medical University of Vienna, Vienna, AustriaMetabolic Unit, Institute of Neuroscience, National Research Council, Padova, ItalyDepartment of Obstetrics and Gynecology, Division of Obstetrics and Feto-Naternal Medicine, Medical University of Vienna, Vienna, AustriaDepartment of Obstetrics and Gynecology, Division of Obstetrics and Feto-Naternal Medicine, Medical University of Vienna, Vienna, AustriaDepartment of Obstetrics and Gynecology, Division of Obstetrics and Feto-Naternal Medicine, Medical University of Vienna, Vienna, AustriaThe aim of this study was to assess the association between OGTT glucose levels and requirement of pharmacotherapy in GDM patients classified by the IADPSG criteria. This study included 203 GDM patients (108 managed with lifestyle modification and 95 requiring pharmacotherapy). Clinical risk factors and OGTT glucose concentrations at 0 (G0), 60 (G60), and 120 min (G120) were collected. OGTT glucose levels were significantly associated with the later requirement of pharmacotherapy (ROC-AUC: 71.1, 95% CI: 63.8–78.3). Also, the combination of clinical risk factors (age, BMI, parity, and pharmacotherapy in previous gestation) showed an acceptable predictive accuracy (ROC-AUC: 72.1, 95% CI: 65.0–79.2), which was further improved when glycemic parameters were added (ROC-AUC: 77.5, 95% CI: 71.5–83.9). Random forest analysis revealed the highest variable importance for G0, G60, and age. OGTT glucose measures in addition to clinical risk factors showed promising properties for risk stratification in GDM patients classified by the recently established IADPSG criteria.http://dx.doi.org/10.1155/2018/3243754
spellingShingle Gülen Yerlikaya
Veronica Falcone
Tina Stopp
Martina Mittlböck
Andrea Tura
Peter Husslein
Wolfgang Eppel
Christian S. Göbl
To Predict the Requirement of Pharmacotherapy by OGTT Glucose Levels in Women with GDM Classified by the IADPSG Criteria
Journal of Diabetes Research
title To Predict the Requirement of Pharmacotherapy by OGTT Glucose Levels in Women with GDM Classified by the IADPSG Criteria
title_full To Predict the Requirement of Pharmacotherapy by OGTT Glucose Levels in Women with GDM Classified by the IADPSG Criteria
title_fullStr To Predict the Requirement of Pharmacotherapy by OGTT Glucose Levels in Women with GDM Classified by the IADPSG Criteria
title_full_unstemmed To Predict the Requirement of Pharmacotherapy by OGTT Glucose Levels in Women with GDM Classified by the IADPSG Criteria
title_short To Predict the Requirement of Pharmacotherapy by OGTT Glucose Levels in Women with GDM Classified by the IADPSG Criteria
title_sort to predict the requirement of pharmacotherapy by ogtt glucose levels in women with gdm classified by the iadpsg criteria
url http://dx.doi.org/10.1155/2018/3243754
work_keys_str_mv AT gulenyerlikaya topredicttherequirementofpharmacotherapybyogttglucoselevelsinwomenwithgdmclassifiedbytheiadpsgcriteria
AT veronicafalcone topredicttherequirementofpharmacotherapybyogttglucoselevelsinwomenwithgdmclassifiedbytheiadpsgcriteria
AT tinastopp topredicttherequirementofpharmacotherapybyogttglucoselevelsinwomenwithgdmclassifiedbytheiadpsgcriteria
AT martinamittlbock topredicttherequirementofpharmacotherapybyogttglucoselevelsinwomenwithgdmclassifiedbytheiadpsgcriteria
AT andreatura topredicttherequirementofpharmacotherapybyogttglucoselevelsinwomenwithgdmclassifiedbytheiadpsgcriteria
AT peterhusslein topredicttherequirementofpharmacotherapybyogttglucoselevelsinwomenwithgdmclassifiedbytheiadpsgcriteria
AT wolfgangeppel topredicttherequirementofpharmacotherapybyogttglucoselevelsinwomenwithgdmclassifiedbytheiadpsgcriteria
AT christiansgobl topredicttherequirementofpharmacotherapybyogttglucoselevelsinwomenwithgdmclassifiedbytheiadpsgcriteria